RT @RichardPAConway: ORAL Surveillance VTE risk. Significant increase in VTE/PE only at 10mg bd dose. Abstr#1941 #ACR21
Tweet Content
ORAL Surveillance VTE risk. Significant increase in VTE/PE only at 10mg bd dose. Abstr#1941 #ACR21 @RheumNow https://t.co/WW71syiINE
Show on Archive Page
On
Display in Search Results
On
PDQ
Off